Is U.S. Drug Pricing Debate Leaving Europe Feeling Good?
Novartis this week said it was seeing better uptake of a potential blockbuster drug in Europe than in the U.S.
Novartis this week said it was seeing better uptake of a potential blockbuster drug in Europe than in the U.S.